About FDA
Number of presentations/participation at U.S. conferences, stakeholder meetings, and trainings during the month
Dictionary: One of OSMP’s primary functions is to train and communicate OSMP issues both internally with FDA staff, and externally with the regulated industry. OSMP staff is frequently invited to participate at universities, conferences, workshops, and training sessions. These activities are intended to foster efficiency and innovative product development, expedite the premarket review process, and enhance the safe and ethical development of therapies by increasing understanding and transparency of the complex regulatory issues raised by medical products.
Information is current as of December 31, 2012.
Fiscal Year - 2010
| Time | Target | Number |
|---|---|---|
| Oct 2009 | N/A | 47 |
| Nov 2009 | N/A | 30 |
| Dec 2009 | N/A | 32 |
| Jan 2010 | N/A | 16 |
| Feb 2010 | N/A | 27 |
| Mar 2010 | N/A | 43 |
| Apr 2010 | N/A | 45 |
| May 2010 | N/A | 30 |
| Jun 2010 | N/A | 46 |
| Jul 2010 | N/A | 27 |
| Aug 2010 | N/A | 50 |
| Sep 2010 | N/A | 32 |
FY 2010 Total: 425
Glossary
Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.
